Role of ASXL1 mutation in myeloid malignancies

Meng Yao Sheng, Yuan Zhou, Ming Jiang Xu, Feng Chun Yang

Research output: Contribution to journalArticle

Abstract

Additional sex comb-like 1 ( ASXL1) is an enhancer of Trithorax and Polycomb family, which are necessary for the maintenance of stable repression of homeotic and other loci. Recently, alterations of ASXL1 gene were identified in the hematopoietic cells from patients with a variety of myeloid malignancies, including chronic myelomonocytic leukemia (CMML, 43% of cases), myelodysplastic syndrome (MDS, 20%), myeloproliferative neoplasms (MPN, 10%) and acute myeloid leukemia (AML, 20%). The majority of ASXL1 mutations are frameshift and nonsense mutations. These clinical data suggest an important role of ASXL1 in the pathogenesis and/or transformation of myeloid malignancies. However, the role of ASXL1 in the pathogenesis of myeloid malignancies and in normal hematopoiesis in vivo, as well as the underlying mechanisms remains unknown. This article reviews the structure and function of ASXL1, the clinical characteristic and prognostic significance of ASXL1 mutation, the association of ASXL1 with other gene mutation, as well as ASXL1 knock-down or silence in vitro and in vivo models.

Original languageEnglish (US)
Pages (from-to)1183-1187
Number of pages5
JournalZhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology
Volume22
Issue number4
DOIs
StatePublished - Aug 1 2014
Externally publishedYes

Fingerprint

Comb and Wattles
Mutation
Neoplasms
Repression (Psychology)
Leukemia, Myelomonocytic, Chronic
Frameshift Mutation
Nonsense Codon
Myelodysplastic Syndromes
Hematopoiesis
Acute Myeloid Leukemia
Genes
Maintenance

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Role of ASXL1 mutation in myeloid malignancies. / Sheng, Meng Yao; Zhou, Yuan; Xu, Ming Jiang; Yang, Feng Chun.

In: Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology, Vol. 22, No. 4, 01.08.2014, p. 1183-1187.

Research output: Contribution to journalArticle

@article{6b92fe6641c644f5bcb2c8591bab6817,
title = "Role of ASXL1 mutation in myeloid malignancies",
abstract = "Additional sex comb-like 1 ( ASXL1) is an enhancer of Trithorax and Polycomb family, which are necessary for the maintenance of stable repression of homeotic and other loci. Recently, alterations of ASXL1 gene were identified in the hematopoietic cells from patients with a variety of myeloid malignancies, including chronic myelomonocytic leukemia (CMML, 43{\%} of cases), myelodysplastic syndrome (MDS, 20{\%}), myeloproliferative neoplasms (MPN, 10{\%}) and acute myeloid leukemia (AML, 20{\%}). The majority of ASXL1 mutations are frameshift and nonsense mutations. These clinical data suggest an important role of ASXL1 in the pathogenesis and/or transformation of myeloid malignancies. However, the role of ASXL1 in the pathogenesis of myeloid malignancies and in normal hematopoiesis in vivo, as well as the underlying mechanisms remains unknown. This article reviews the structure and function of ASXL1, the clinical characteristic and prognostic significance of ASXL1 mutation, the association of ASXL1 with other gene mutation, as well as ASXL1 knock-down or silence in vitro and in vivo models.",
author = "Sheng, {Meng Yao} and Yuan Zhou and Xu, {Ming Jiang} and Yang, {Feng Chun}",
year = "2014",
month = "8",
day = "1",
doi = "10.7534/j.issn.1009-2137.2014.04.057",
language = "English (US)",
volume = "22",
pages = "1183--1187",
journal = "Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology",
issn = "1009-2137",
publisher = "Haidian-qu",
number = "4",

}

TY - JOUR

T1 - Role of ASXL1 mutation in myeloid malignancies

AU - Sheng, Meng Yao

AU - Zhou, Yuan

AU - Xu, Ming Jiang

AU - Yang, Feng Chun

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Additional sex comb-like 1 ( ASXL1) is an enhancer of Trithorax and Polycomb family, which are necessary for the maintenance of stable repression of homeotic and other loci. Recently, alterations of ASXL1 gene were identified in the hematopoietic cells from patients with a variety of myeloid malignancies, including chronic myelomonocytic leukemia (CMML, 43% of cases), myelodysplastic syndrome (MDS, 20%), myeloproliferative neoplasms (MPN, 10%) and acute myeloid leukemia (AML, 20%). The majority of ASXL1 mutations are frameshift and nonsense mutations. These clinical data suggest an important role of ASXL1 in the pathogenesis and/or transformation of myeloid malignancies. However, the role of ASXL1 in the pathogenesis of myeloid malignancies and in normal hematopoiesis in vivo, as well as the underlying mechanisms remains unknown. This article reviews the structure and function of ASXL1, the clinical characteristic and prognostic significance of ASXL1 mutation, the association of ASXL1 with other gene mutation, as well as ASXL1 knock-down or silence in vitro and in vivo models.

AB - Additional sex comb-like 1 ( ASXL1) is an enhancer of Trithorax and Polycomb family, which are necessary for the maintenance of stable repression of homeotic and other loci. Recently, alterations of ASXL1 gene were identified in the hematopoietic cells from patients with a variety of myeloid malignancies, including chronic myelomonocytic leukemia (CMML, 43% of cases), myelodysplastic syndrome (MDS, 20%), myeloproliferative neoplasms (MPN, 10%) and acute myeloid leukemia (AML, 20%). The majority of ASXL1 mutations are frameshift and nonsense mutations. These clinical data suggest an important role of ASXL1 in the pathogenesis and/or transformation of myeloid malignancies. However, the role of ASXL1 in the pathogenesis of myeloid malignancies and in normal hematopoiesis in vivo, as well as the underlying mechanisms remains unknown. This article reviews the structure and function of ASXL1, the clinical characteristic and prognostic significance of ASXL1 mutation, the association of ASXL1 with other gene mutation, as well as ASXL1 knock-down or silence in vitro and in vivo models.

UR - http://www.scopus.com/inward/record.url?scp=84921629469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921629469&partnerID=8YFLogxK

U2 - 10.7534/j.issn.1009-2137.2014.04.057

DO - 10.7534/j.issn.1009-2137.2014.04.057

M3 - Article

VL - 22

SP - 1183

EP - 1187

JO - Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

JF - Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

SN - 1009-2137

IS - 4

ER -